AstraZeneca wins over UK doctors
10 September 2009
Medical representatives from AstraZeneca came out top with UK doctors in a survey conducted by Doctors.net.uk.
More than 600 primary and secondary care doctors were asked to vote for representatives they valued in terms of communication skills, technical skills as well as for those they most enjoyed meeting. AstraZeneca was the most highly rated but a number of smaller firms also did well compared with the bigger companies, including Takeda, Ferring and Eisai.
The complete Top Ten are as follows: Eli Lilly, Pfizer, GlaxoSmithKline, Janssen Cilag, Sanofi-aventis, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb and Merck Sharpe & Dohme.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
